Cosmo Pharmaceuticals NV (COPN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cosmo Pharmaceuticals NV (COPN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7379
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of various gastro-intestinal tract, inflammatory bowel diseases, colon infections and colon diagnosis, among others. Cosmo also provides SIC 8000, a submucosal injectable composition for extracting polyps and adenomas; and other products. The company manufactures products for oral administration such as tablets, capsules, powders and syrups; topical dosage forms such as emulsions, gels, ointments and injectables, among others. Its manufacturing facility is located in Lainate, Milan. Cosmo is headquartered in Dublin, Ireland.

Cosmo Pharmaceuticals NV (COPN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cosmo Pharmaceuticals NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cosmo Pharmaceuticals NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cosmo Pharmaceuticals NV, Medical Equipment, Deal Details 10
Partnerships 10
Cosmo Pharmaceuticals Expands Agreement with FujiFilm Europe 10
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 11
Equity Offering 12
Cosmo Pharma Raises USD215.5 Million in Private Placement of Shares 12
Cosmo Pharma Raises USD103.4 Million in private placement of Shares 13
Cosmo Pharmaceuticals NV – Key Competitors 14
Cosmo Pharmaceuticals NV – Key Employees 15
Cosmo Pharmaceuticals NV – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Jul 26, 2018: Cosmo Half-Year report 2018 17
Corporate Communications 18
Jun 01, 2017: Cosmo appoints new Head of Investor Relations 18
May 17, 2017: Cosmo Pharmaceuticals Announces Appointment Of Non-Executive Board Member 19
Legal and Regulatory 20
Apr 12, 2018: Cosmo Pharmaceuticals announces unfavourable award of Arbitral Tribunal in respect of request to terminate Uceris License Agreement with Valeant 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Cosmo Pharmaceuticals NV, Medical Equipment, Key Facts, 2017 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cosmo Pharmaceuticals NV, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cosmo Pharmaceuticals NV, Deals By Market, 2012 to YTD 2018 8
Cosmo Pharmaceuticals NV, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cosmo Pharmaceuticals Expands Agreement with FujiFilm Europe 10
Cosmo Pharma Enters into Co-Promotion Agreement with Olympus America 11
Cosmo Pharma Raises USD215.5 Million in Private Placement of Shares 12
Cosmo Pharma Raises USD103.4 Million in private placement of Shares 13
Cosmo Pharmaceuticals NV, Key Competitors 14
Cosmo Pharmaceuticals NV, Key Employees 15
Cosmo Pharmaceuticals NV, Subsidiaries 16

List of Figures
Cosmo Pharmaceuticals NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cosmo Pharmaceuticals NV, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cosmo Pharmaceuticals NV, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cosmo Pharmaceuticals NV, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cosmo Pharmaceuticals NV (COPN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hamilton Thorne Ltd (HTL):企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • Virgin Media Inc.:企業の戦略的SWOT分析
    Virgin Media Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • TCR (London) Ltd :企業の戦略・SWOT・財務情報
    TCR (London) Ltd - Strategy, SWOT and Corporate Finance Report Summary TCR (London) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Shearman & Sterling LLP:企業の戦略的SWOT分析
    Shearman & Sterling LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kingdom Hotel Investments:企業の戦略・SWOT・財務分析
    Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report Summary Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sigma Pharmaceuticals Limited:企業の戦略・SWOT・財務情報
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Kongsberg Maritime AS-石油・ガス分野:企業M&A・提携分析
    Summary Kongsberg Maritime AS (Kongsberg Maritime), a subsidiary of Kongsberg Gruppen AS, is a provider of merchant marine, subsea and offshore solutions. The company offers a wide range of products that include bridge systems, camera systems, deck systems, engine room and automation systems, inform …
  • Miele & Cie. KG:企業の戦略的SWOT分析
    Miele & Cie. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Nuclear Power Corporation of India Ltd:電力:M&Aディール及び事業提携情報
    Summary Nuclear Power Corporation of India Ltd (NPCIL) designs, constructs, commissions and operates nuclear power reactors. The company operates atomic power plants and executes atomic power projects for electricity generation. It is administered by the Department of Atomic Energy (DAE), Government …
  • Edgars Stores Limited:企業の戦略・SWOT・財務情報
    Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PipeHawk Plc:企業の戦略・SWOT・財務分析
    PipeHawk Plc - Strategy, SWOT and Corporate Finance Report Summary PipeHawk Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China Huaneng Group:企業の発電所・SWOT分析2018
    China Huaneng Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • REC Silicon ASA (REC):電力:M&Aディール及び事業提携情報
    Summary REC Silicon ASA (REC Silicon), formerly Renewable Energy Corporation ASA, is a producer of advanced silicon materials, and delivers high-purity polysilicon and silicon gas. Its products find application in the solar and electronics industries in the production of solar panels, flat panel dis …
  • Syneron Medical Ltd:企業の戦略的SWOT分析
    Syneron Medical Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Teladoc Health Inc (TDOC):企業の財務・戦略的SWOT分析
    Summary Teladoc Health Inc (Teladoc Health), formerly TelaDoc Inc, is a provider of virtual healthcare services for wellness and prevention of acute care and complex healthcare needs. It offers primary care services managing chronic conditions; mental health guidance; personalized digital healthcare …
  • Sempra Energy (SRE):石油・ガス:M&Aディール及び事業提携情報
    Summary Sempra Energy (Sempra) is an energy-services holding company. Through its subsidiaries, the company invests in, develops, and operates energy infrastructure. It carries out utility operations, development of energy infrastructure and related services in countries including the US, Mexico, Ar …
  • Traverse Energy Ltd (TVL):企業の財務・戦略的SWOT分析
    Summary Traverse Energy Ltd (Traverse Energy), formerly Firstland Energy Ltd is an oil and gas company that explores, produces, and develops petroleum and natural gas assets. The company's products include crude oil, natural gas, petroleum products, and associated liquids, among others. It explores …
  • Cellerant Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cellerant Therapeutics Inc (Cellerant) develops novel immunotherapies for oncology and blood-related disorders. Its lead product, CLT-008, is a myeloid progenitor cell therapy which is in Phase 2 clinical development in patients with acute myeloid leukemia (AML). Cellerant develops various c …
  • bioMerieux SA (BIM):企業の財務・戦略的SWOT分析
    bioMerieux SA (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆